Display options
Cite
Rubini Giménez M, Miller PE, Alviar CL, et al. Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial. J Clin Med. 2020;9(3)doi: 10.3390/jcm9030860.
Rubini Giménez, M., Miller, P. E., Alviar, C. L., van Diepen, S., Granger, C. B., Montalescot, G., Windecker, S., Maier, L., Serpytis, P., Serpytis, R., Oldroyd, K. G., Noc, M., Fuernau, G., Huber, K., Sandri, M., de Waha-Thiele, S., Schneider, S., Ouarrak, T., Zeymer, U., Desch, S., & Thiele, H. (2020). Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial. Journal of clinical medicine, 9(3), . https://doi.org/10.3390/jcm9030860
Rubini Giménez, Maria, et al. "Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial." Journal of clinical medicine vol. 9,3 (2020). doi: https://doi.org/10.3390/jcm9030860
Rubini Giménez M, Miller PE, Alviar CL, van Diepen S, Granger CB, Montalescot G, Windecker S, Maier L, Serpytis P, Serpytis R, Oldroyd KG, Noc M, Fuernau G, Huber K, Sandri M, de Waha-Thiele S, Schneider S, Ouarrak T, Zeymer U, Desch S, Thiele H. Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial. J Clin Med. 2020 Mar 20;9(3). doi: 10.3390/jcm9030860. PMID: 32245139; PMCID: PMC7141492.
Copy Download .nbib Format: NLM
Share it on

J Clin Med. 2020 Mar 20;9(3). doi: 10.3390/jcm9030860.

Outcomes Associated with Respiratory Failure for Patients with Cardiogenic Shock and Acute Myocardial Infarction: A Substudy of the CULPRIT-SHOCK Trial.

Journal of clinical medicine

Maria Rubini Giménez, P Elliott Miller, Carlos L Alviar, Sean van Diepen, Christopher B Granger, Gilles Montalescot, Stephan Windecker, Lars Maier, Pranas Serpytis, Rokas Serpytis, Keith G Oldroyd, Marko Noc, Georg Fuernau, Kurt Huber, Marcus Sandri, Suzanne de Waha-Thiele, Steffen Schneider, Taoufik Ouarrak, Uwe Zeymer, Steffen Desch, Holger Thiele

Affiliations

  1. Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig and Leipzig Heart Institute, 04289 Leipzig, Germany.
  2. Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, 4031 Basel, Switzerland.
  3. Division of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06520-8017, USA.
  4. Yale National Clinician Scholars Program, New Haven, CT 06510-8088, USA.
  5. The Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, NY 10016, USA.
  6. Department of Critical Care Medicine and Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, AB 8440, Canada.
  7. Cardiology Department, Duke Clinical Research Institute, Durham, NC 27701, USA.
  8. Department of Cardiology, Institut de Cardiologie (AP-HP), Hôpital Pitié Salpêtrière, Sorbonne Université, ACTION study group, 75013 Paris, France.
  9. Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
  10. Department of Cardiology, University Hospital Regensburg, 93077 Regensburg, Germany.
  11. Faculty of Medicine, Vilnius University and Vilnius University Hospital Santaros Klinikos, 08410 Vilnius, Lithuania.
  12. Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, UK.
  13. Cardiology Department, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.
  14. Cardiology Department, University Heart Center Luebeck, 23538 Luebeck, Germany.
  15. 3rd Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital and Sigmund Freud University, Medical School, 2301 Vienna, Austria.
  16. Statistical department, Institut für Herzinfarktforschung, 67063 Ludwigshafen, Germany.
  17. Hospital of the city of Ludwigshafen, Medical Clinic B and Institut für Herzinfarktforschung, 67063 Ludwigshafen, Germany.

PMID: 32245139 PMCID: PMC7141492 DOI: 10.3390/jcm9030860

Abstract

BACKGROUND: Little is known about clinical outcomes of patients with acute myocardial infraction (AMI) complicated by cardiogenic shock (CS) requiring mechanical ventilation (MV). The aim of this study was to identify the characteristics, risk factors, and outcomes associated with the provision of MV in this specific high-risk population.

METHODS: Patients with CS complicating AMI and multivessel coronary artery disease from the CULPRIT-SHOCK trial were included. We explored 30 days of clinical outcomes in patients not requiring MV, those with MV on admission, and those in whom MV was initiated within the first day after admission.

RESULTS: Among 683 randomized patients included in the analysis, 17.4% received no MV, 59.7% were ventilated at admission and 22.8% received MV within or after the first day after admission. Patients requiring MV had a different risk-profile. Factors independently associated with the provision of MV on admission included higher body weight, resuscitation within 24 h before admission, elevated heart rate and evidence of triple vessel disease.

CONCLUSIONS: Requiring MV in patients with CS complicating AMI is common and independently associated with mortality after adjusting for covariates. Patients with delayed MV initiation appear to be at higher risk of adverse outcomes. Further research is necessary to identify the optimal timing of MV in this high-risk population.

Keywords: cardiogenic shock; mechanical ventilation; non-invasive ventilation; respiratory failure

References

  1. N Engl J Med. 2017 Dec 21;377(25):2419-2432 - PubMed
  2. Heart. 2013 Dec;99(24):1812-7 - PubMed
  3. N Engl J Med. 2004 Jun 10;350(24):2452-60 - PubMed
  4. Catheter Cardiovasc Interv. 2019 Jul 1;94(1):29-37 - PubMed
  5. Eur Heart J. 2019 Aug 21;40(32):2671-2683 - PubMed
  6. Clin Res Cardiol. 2011 Mar;100(3):235-9 - PubMed
  7. Am J Cardiol. 1983 Sep 1;52(5):588-93 - PubMed
  8. JAMA. 2007 Apr 18;297(15):1657-66 - PubMed
  9. Circulation. 2017 Oct 17;136(16):e232-e268 - PubMed
  10. Int J Cardiol. 2017 Mar 1;230:191-197 - PubMed
  11. J Appl Physiol (1985). 1988 Sep;65(3):1244-50 - PubMed
  12. J Am Coll Cardiol. 2019 Apr 16;73(14):1781-1791 - PubMed
  13. Eur J Heart Fail. 2020 Jan;22(1):168 - PubMed
  14. Cardiovasc Diabetol. 2019 Sep 30;18(1):126 - PubMed
  15. J Am Coll Cardiol. 2018 Sep 25;72(13):1532-1553 - PubMed
  16. Am Heart J. 2006 Sep;152(3):469.e1-8 - PubMed
  17. J Am Coll Cardiol. 2017 Jan 24;69(3):358-360 - PubMed
  18. Am Heart J. 2016 Feb;172:160-9 - PubMed
  19. Int J Cardiol. 2013 Oct 9;168(4):3954-62 - PubMed
  20. Eur Heart J. 2018 Jan 1;39(1):17-25 - PubMed
  21. Diabetol Metab Syndr. 2018 Jan 3;10:1 - PubMed
  22. Crit Care Med. 1982 Jun;10(6):358-60 - PubMed
  23. N Engl J Med. 2012 Oct 4;367(14):1287-96 - PubMed
  24. JAMA. 2002 Jan 16;287(3):345-55 - PubMed
  25. N Engl J Med. 1999 Aug 26;341(9):625-34 - PubMed
  26. Eur J Heart Fail. 2019 Nov;21(11):1370-1378 - PubMed
  27. N Engl J Med. 2018 Nov 1;379(18):1699-1710 - PubMed
  28. J Am Coll Cardiol. 2019 Oct 29;74(17):2117-2128 - PubMed
  29. Circulation. 2011 Jun 14;123(23):2736-47 - PubMed

Publication Types

Grant support